Natural killer cell activity and cytokine production

Natural killer (NK) cell activity and cytokine production represent the primary effector functions of NK cells, a lineage of innate lymphoid cells essential for host defense against pathogens and tumors (Vivier et al., 2011, Science). NK cell activity is characterized by direct cytotoxicity, mediated by the release of perforin and granzymes, and the production of immunomodulatory cytokines such as interferon-gamma (IFN-gamma) and tumor necrosis factor (TNF) (Paul & Lal, 2017, Frontiers in Immunology). These processes are regulated by a complex balance of activating and inhibitory signals from surface receptors like NKG2D, CD16, and Killer-cell Immunoglobulin-like Receptors (KIRs) (Shimasaki et al., 2020, Nature Reviews Drug Discovery). In clinical contexts, enhancing NK cell activity is a key goal of cancer immunotherapies, including the use of cytokines like Aldesleukin (IL-2) and monoclonal antibodies that facilitate antibody-dependent cellular cytotoxicity (ADCC) (Morvan & Lanier, 2016, Nature Reviews Cancer). Conversely, dysregulated NK cell activity can contribute to chronic inflammation or autoimmune disorders, making these pathways targets for immunosuppressive therapies. Because this entry describes a physiological process and endpoint rather than a specific molecular entity, it is classified as an incorrect target designation for structured drug-target interaction databases.

Other names

NK cell activationNatural killer cell mediated cytotoxicityNK cell cytokine secretionNK cell effector function

Modulation of NK cell activity occurs through the stimulation of activating receptors (e.g., CD16, NKG2D), the blockade of inhibitory receptors (e.g., KIRs, NKG2A), or the administration of exogenous cytokines (e.g., IL-2, IL-15) to enhance cytotoxicity and IFN-gamma production.